A decision is expected in the fourth quarter of 2025.

Cost is a barrier to care for chronic and rare diseases, so financial assistance is way to lower that barrier and help people ...

In January 2023, the Brukinsa, a next-generation BTK inhibitor, received FDA approval for chronic lymphocytic leukemia (CLL).

In mice with human Merkel cell carcinoma, pyrvinium pamoate significantly reduced tumor growth, potentially offering a new ...

Digital pharmacy solutions can help brick and mortar locations become more efficient, according to Sarah Thomas, VP of sales ...

Cigna Healthcare’s medical care ratio increased to 82.2% in the first quarter compared with 79.9% in the first quarter of ...

Treating hidradenitis suppurativa is complex and often requires taking a number of medications, including antibiotics, ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.

Payers and providers, often depicted as rivals, are on the same side when it comes to the 340B program that allows some ...

The new research center at the University of Michigan and Oregon Health & Science University intends to develop a clinical ...

A growing and more diverse pipeline means that there is a greater need for digital innovations, which can address ...